PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis

Motivation: A current challenge in understanding cancer processes is to pinpoint which mutations influence the onset and progression of disease. Toward this goal, we describe a method called PARADIGM-SHIFT that can predict whether a mutational event is neutral, gain-or loss-of-function in a tumor sample. The method uses a belief-propagation algorithm to infer gene activity from gene expression and copy number data in the context of a set of pathway interactions. Results: The method was found to be both sensitive and specific on a set of positive and negative controls for multiple cancers for which pathway information was available. Application to the Cancer Genome Atlas glioblastoma, ovarian and lung squamous cancer datasets revealed several novel mutations with predicted high impact including several genes mutated at low frequency suggesting the approach will be complementary to current approaches that rely on the prevalence of events to reach statistical significance. Availability: All source code is available at the github repository http:github.org/paradigmshift. Contact: jstuart@soe.ucsc.edu Supplementary information: Supplementary data are available at Bioinformatics online.

[1]  M. N. Lebbink,et al.  Focused ion beam‐scanning electron microscope: exploring large volumes of atherosclerotic tissue , 2009, Journal of microscopy.

[2]  Guy Cavet,et al.  Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers" , 2007, Science.

[3]  Ben Lich,et al.  DualBeam Slice & View: Practical Aspects for Collecting 3D Cortex Image Data , 2006, Microscopy and Microanalysis.

[4]  Nir Friedman,et al.  Inferring Cellular Networks Using Probabilistic Graphical Models , 2004, Science.

[5]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[6]  Shannon McWeeney,et al.  Genetic diversity and striatal gene networks: focus on the heterogeneous stock-collaborative cross (HS-CC) mouse , 2010, BMC Genomics.

[7]  C. Sander,et al.  Determinants of protein function revealed by combinatorial entropy optimization , 2007, Genome Biology.

[8]  L. Stein,et al.  A human functional protein interaction network and its application to cancer data analysis , 2010, Genome Biology.

[9]  Lu Chen,et al.  Bidirectional ephrin/Eph signaling in synaptic functions , 2007, Brain Research.

[10]  David Haussler,et al.  Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..

[11]  A. Gonzalez-Perez,et al.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.

[12]  M. Serrano,et al.  A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. , 2007, Genes & development.

[13]  Joshua M. Stuart,et al.  Subtype and pathway specific responses to anticancer compounds in breast cancer , 2011, Proceedings of the National Academy of Sciences.

[14]  Sean D Mooney,et al.  Bioinformatic tools for identifying disease gene and SNP candidates. , 2010, Methods in molecular biology.

[15]  Joris M. Mooij,et al.  libDAI: A Free and Open Source C++ Library for Discrete Approximate Inference in Graphical Models , 2010, J. Mach. Learn. Res..

[16]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[17]  W. Denk,et al.  Serial Block-Face Scanning Electron Microscopy to Reconstruct Three-Dimensional Tissue Nanostructure , 2004, PLoS biology.

[18]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.